- Home
- FLYE vs ADVB Comparison
FLYE vs ADVB Comparison
Compare FLYE & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYE
- ADVB
- Stock Information
- Founded
- FLYE 2018
- ADVB 2014
- Country
- FLYE United States
- ADVB United States
- Employees
- FLYE N/A
- ADVB N/A
- Industry
- FLYE Aerospace
- ADVB Medical Specialities
- Sector
- FLYE Industrials
- ADVB Health Care
- Exchange
- FLYE Nasdaq
- ADVB Nasdaq
- Market Cap
- FLYE 8.5M
- ADVB 9.7M
- IPO Year
- FLYE 2024
- ADVB 2025
- Fundamental
- Price
- FLYE $4.06
- ADVB $0.45
- Analyst Decision
- FLYE
- ADVB
- Analyst Count
- FLYE 0
- ADVB 0
- Target Price
- FLYE N/A
- ADVB N/A
- AVG Volume (30 Days)
- FLYE 55.2K
- ADVB 1.7M
- Earning Date
- FLYE 11-19-2025
- ADVB 11-19-2025
- Dividend Yield
- FLYE N/A
- ADVB N/A
- EPS Growth
- FLYE N/A
- ADVB N/A
- EPS
- FLYE N/A
- ADVB N/A
- Revenue
- FLYE $22,881,935.00
- ADVB N/A
- Revenue This Year
- FLYE N/A
- ADVB N/A
- Revenue Next Year
- FLYE N/A
- ADVB N/A
- P/E Ratio
- FLYE N/A
- ADVB N/A
- Revenue Growth
- FLYE N/A
- ADVB N/A
- 52 Week Low
- FLYE $3.83
- ADVB $0.34
- 52 Week High
- FLYE $166.00
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- FLYE 56.83
- ADVB 49.42
- Support Level
- FLYE $5.37
- ADVB $0.36
- Resistance Level
- FLYE $4.21
- ADVB $0.49
- Average True Range (ATR)
- FLYE 0.34
- ADVB 0.04
- MACD
- FLYE -0.20
- ADVB -0.00
- Stochastic Oscillator
- FLYE 10.09
- ADVB 52.41
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.